Endpoints News· Maggie Fick·· 2 天前AI 评分36
Roche 调整计划凸显 MFN 如何令欧洲药品上市复杂化
Roche’s changing plans show how MFN is complicating European drug launches
AI 导读
Roche 将推迟为其乳腺癌口服新药 giredestrant 申请欧洲批准，时间晚于此前预期。这一调整凸显美国药价压力正使欧洲药品上市变得更加复杂。
正文 · 原文
Roche will seek European approval for its promising new breast cancer pill giredestrant later than it once expected, highlighting how US drug pricing pressure may …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源：Endpoints News · endpoints.news